193 related articles for article (PubMed ID: 19691429)
21. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
22. Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection.
Chen MY; Hung CC; Lee KL
Virol J; 2015 Jun; 12():94. PubMed ID: 26088443
[TBL] [Abstract][Full Text] [Related]
23. Parvovirus PARV4 visualization and detection.
Tuke PW; Parry RP; Appleton H
J Gen Virol; 2010 Feb; 91(Pt 2):541-4. PubMed ID: 19846677
[TBL] [Abstract][Full Text] [Related]
24. Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
Slavov SN; Otaguiri KK; Smid J; de Oliveira AC; Casseb J; Martinez EZ; Covas DT; Eis-Hübinger AM; Kashima S
J Med Virol; 2017 Apr; 89(4):748-752. PubMed ID: 27589576
[TBL] [Abstract][Full Text] [Related]
25. Parvovirus B19 infection in patients with hemophilia.
Ragni MV; Koch WC; Jordan JA
Transfusion; 1996 Mar; 36(3):238-41. PubMed ID: 8604509
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4.
Lau SKP; Woo PCY; Tse H; Fu CTY; Au WK; Chen XC; Tsoi HW; Tsang THF; Chan JSY; Tsang DNC; Li KSM; Tse CWS; Ng TK; Tsang OTY; Zheng BJ; Tam S; Chan KH; Zhou B; Yuen KY
J Gen Virol; 2008 Aug; 89(Pt 8):1840-1848. PubMed ID: 18632954
[TBL] [Abstract][Full Text] [Related]
27. Studies on the inactivation of human parvovirus 4.
Baylis SA; Tuke PW; Miyagawa E; Blümel J
Transfusion; 2013 Oct; 53(10 Pt 2):2585-92. PubMed ID: 24032592
[TBL] [Abstract][Full Text] [Related]
28. Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A; Kivelä P; Hedman L; Kumar A; Kantele A; Lappalainen M; Liitsola K; Ristola M; Delwart E; Sharp C; Simmonds P; Söderlund-Venermo M; Hedman K
Emerg Infect Dis; 2011 Jan; 17(1):79-82. PubMed ID: 21192859
[TBL] [Abstract][Full Text] [Related]
29. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan.
Chen MY; Yang SJ; Hung CC
Emerg Infect Dis; 2011 Oct; 17(10):1954-6. PubMed ID: 22000381
[TBL] [Abstract][Full Text] [Related]
30. Analysis of two human parvovirus PARV4 genotypes identified in human plasma for fractionation.
Fryer JF; Delwart E; Bernardin F; Tuke PW; Lukashov VV; Baylis SA
J Gen Virol; 2007 Aug; 88(Pt 8):2162-2167. PubMed ID: 17622618
[TBL] [Abstract][Full Text] [Related]
31. Development of an enzyme-linked immunosorbent assay to detect chicken parvovirus-specific antibodies.
Strother KO; Zsak L
Avian Dis; 2009 Dec; 53(4):585-91. PubMed ID: 20095161
[TBL] [Abstract][Full Text] [Related]
32. Identification of human parvovirus 4 genotypes 1 and 2 in Chinese source plasma pools.
Jia J; Zhong Y; Zhang H; Yuan D; Ma L; Wang D; Zhang J; Ma Y
J Med Virol; 2021 Aug; 93(8):4780-4785. PubMed ID: 33200412
[TBL] [Abstract][Full Text] [Related]
33. Human parvovirus 4 infection among mothers and children in South Africa.
Matthews PC; Sharp CP; Malik A; Gregory WF; Adland E; Jooste P; Goulder PJ; Simmonds P; Klenerman P
Emerg Infect Dis; 2015 Apr; 21(4):713-5. PubMed ID: 25812109
[No Abstract] [Full Text] [Related]
34. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V).
Corcioli F; Zakrzewska K; Fanci R; De Giorgi V; Innocenti M; Rotellini M; Di Lollo S; Azzi A
Virol J; 2010 Oct; 7():272. PubMed ID: 20950445
[TBL] [Abstract][Full Text] [Related]
35. Persistence of novel human parvovirus PARV4 in liver tissue of adults.
Schneider B; Fryer JF; Reber U; Fischer HP; Tolba RH; Baylis SA; Eis-Hübinger AM
J Med Virol; 2008 Feb; 80(2):345-51. PubMed ID: 18098166
[TBL] [Abstract][Full Text] [Related]
36. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
37. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
38. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
Schneider B; Fryer JF; Oldenburg J; Brackmann HH; Baylis SA; Eis-Hübinger AM
Haemophilia; 2008 Sep; 14(5):978-86. PubMed ID: 18565125
[TBL] [Abstract][Full Text] [Related]
39. Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors.
Lurcharchaiwong W; Chieochansin T; Payungporn S; Theamboonlers A; Poovorawan Y
Infection; 2008 Oct; 36(5):488-91. PubMed ID: 18759058
[No Abstract] [Full Text] [Related]
40. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
